Skip to main content
Sunshine Biopharma Inc. logo

Sunshine Biopharma Inc. — Investor Relations & Filings

Ticker · SBFM ISIN · US8677817004 LEI · 5299005Y64EHRQDQ2Q25 US Manufacturing
Open in API
Filings indexed 382 across all filing types
Latest filing 2013-02-25 Regulatory Filings
Country US United States of America
Listing US SBFM

About Sunshine Biopharma Inc.

https://www.sunshinebiopharma.com/

Sunshine Biopharma Inc. is a pharmaceutical company engaged in the research, development, and commercialization of life-saving medicines. The company's primary focus is on various therapeutic areas, with a significant emphasis on oncology and antiviral treatments.

Recent filings

Filing Released Lang Actions
CURRENT REPORT
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated February 25, 2013. It announces a change in the company's certifying accountant, detailing the termination of the previous auditor due to dissolution and the appointment of a new auditor for the upcoming fiscal year. The document includes no actual financial statements or detailed financial data but rather reports on the change in auditor and related correspondence. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not constitute a full audit report or annual report itself. The document length is 4460 characters, which is relatively short and consistent with an announcement rather than a full report.
2013-02-25 English
CURRENT REPORT
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated November 28, 2012. It provides updates on the company's drug development progress, including IND-enabling studies, GMP manufacturing plans, patent applications, and clinical trial plans. The content focuses on recent events and progress rather than comprehensive financial data or detailed financial statements. The document length is 3170 characters, which is relatively short and consistent with a current report rather than a full annual or quarterly report. The nature of the information aligns with a regulatory announcement of significant company events rather than a financial report or management discussion. Therefore, the document fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous SEC filings like Form 8-K that do not fit other specific categories.
2012-11-29 English
QUARTERLY REPORT
Interim / Quarterly Report 9M 2012
2012-11-08 English
PRIMARY DOCUMENT
Director's Dealing
2012-10-05 English
PRIMARY DOCUMENT
Director's Dealing
2012-09-07 English
Regulatory Filings 2012
Regulatory Filings
2012-08-23 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.